These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. Kim SY; Shin SJ; Jeong BH; Koh WJ BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic studies in patients with nontuberculous mycobacterial lung infections. Magis-Escurra C; Alffenaar JW; Hoefnagels I; Dekhuijzen PN; Boeree MJ; van Ingen J; Aarnoutse RE Int J Antimicrob Agents; 2013 Sep; 42(3):256-61. PubMed ID: 23837923 [TBL] [Abstract][Full Text] [Related]
6. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria. van Ingen J; Boeree MJ; van Soolingen D; Mouton JW Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Other Nontuberculous Mycobacteria. Basille D; Jounieaux V; Andréjak C Semin Respir Crit Care Med; 2018 Jun; 39(3):377-382. PubMed ID: 30071552 [TBL] [Abstract][Full Text] [Related]
9. [Distribution and drug resistance of nontuberculous Zhang J; Su JR; Ding BC; Liu JW; Yi JL; Yang XY; Wang NH; Wang SM Zhonghua Jie He He Hu Xi Za Zhi; 2017 Mar; 40(3):210-214. PubMed ID: 28297817 [No Abstract] [Full Text] [Related]
10. Management of nontuberculous mycobacterial infection in the elderly. Mirsaeidi M; Farshidpour M; Ebrahimi G; Aliberti S; Falkinham JO Eur J Intern Med; 2014 Apr; 25(4):356-63. PubMed ID: 24685313 [TBL] [Abstract][Full Text] [Related]
11. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran. Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990 [TBL] [Abstract][Full Text] [Related]
12. Management of nontuberculous mycobacterial (NTM) lung disease. Philley JV; Griffith DE Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract]. Andréjak C; Lescure FX; Schmit JL; Jounieaux V Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937 [TBL] [Abstract][Full Text] [Related]
14. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense. Chu HS; Chang SC; Shen EP; Hu FR PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038 [TBL] [Abstract][Full Text] [Related]
16. Implication of species change of Nontuberculous Mycobacteria during or after treatment. Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802 [TBL] [Abstract][Full Text] [Related]
17. Chronic Mycobacterium avium skin and soft tissue infection complicated with scalp osteomyelitis possibly secondary to anti-interferon-γ autoantibody formation. Xu X; Lao X; Zhang C; Cao C; Ding H; Pang Y; Ning Q; Zou J; Zang N; Hu D; Chen M BMC Infect Dis; 2019 Feb; 19(1):203. PubMed ID: 30819109 [TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility and MIC distribution of 41 drugs against clinical isolates from China and reference strains of nontuberculous mycobacteria. Li G; Pang H; Guo Q; Huang M; Tan Y; Li C; Wei J; Xia Y; Jiang Y; Zhao X; Liu H; Zhao LL; Liu Z; Xu D; Wan K Int J Antimicrob Agents; 2017 Mar; 49(3):364-374. PubMed ID: 28131606 [TBL] [Abstract][Full Text] [Related]
20. Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus. Kishida D; Sato M; Kobayashi C; Ueno KI; Kinoshita T; Kodaira M; Shimojima Y; Ishii W; Ushiki A; Ikeda SI Intern Med; 2017; 56(10):1253-1257. PubMed ID: 28502947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]